Location: Minnetonka, MN
CIK: 0001683689 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $242M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NEO | NeoGenomics Inc. | 2,023,355 | $91.39M | 37.8% | $45.17 | $23.81 | +89.7% | COM NEW | 64049M209 |
| — | Horizon Therapeutics Public Limited Company | 546,775 | $51.2M | 21.2% | $93.64 | $67.70 | — | SHS | G46188101 |
| VCEL | Vericel Corporation | 539,475 | $28.32M | 11.7% | $52.50 | $14.84 | +253.8% | COM | 92346J108 |
| IEFA | ISHARES TR | 340,128 | $25.46M | 10.5% | $74.86 | $73.30 | +2.1% | CORE MSCI EAFE | 46432F842 |
| IEMG | ISHARES TR | 271,766 | $18.21M | 7.5% | $66.99 | $65.80 | +1.8% | CORE MSCI EMKT | 46434G103 |
| FIVN | Five9, Inc. | 91,527 | $16.79M | 6.9% | $183.39 | $104.22 | +76.0% | COM | 338307101 |
| — | JAMF HOLDING CORP | 293,460 | $9.851M | 4.1% | $33.57 | $33.57 | — | COM | 47074L105 |
| IVV | ISHARES TR | 292 | $126K | 0.1% | $431.51 | $332.80 | +29.2% | CORE S&P500 ETF | 464287200 |
| ISTB | ISHARES TR | 2,050 | $105K | 0.0% | $51.22 | $51.57 | -0.5% | CORE 1 5 YR USD | 46432F859 |
| IAGG | ISHARES TR | 783 | $43,000 | 0.0% | $54.92 | $55.67 | -1.0% | CORE INTL AGGR | 46435G672 |
| IJH | ISHARES TR | 147 | $40,000 | 0.0% | $272.11 * | $37.39 | +43.8% | CORE S&P MCP ETF | 464287507 |
| IMTB | ISHARES TR | 764 | $39,000 | 0.0% | $51.05 | $52.45 | -2.0% | CR 5 10 YR ETF | 46435G417 |
| IJR | ISHARES TR | 207 | $23,000 | 0.0% | $111.11 | $71.67 | +57.6% | CORE S&P SCP ETF | 464287804 |